Indivior PLC
INDV21.180USD
+0.130+0.62%
交易中 （美東）報價延遲15分鐘
2.65B總市值
虧損本益比TTM
關於 Indivior PLC 公司
Indivior PLC 是一家制藥公司。該公司致力於開發治療物質使用障礙 (SUD)、嚴重精神疾病和阿片類藥物過量的藥物。該公司擁有一系列候選產品，旨在治療其他慢性病和 SUD 的併發疾病，包括酒精使用障礙和大麻使用障礙，以及包括精神分裂症在內的合併症。其核心產品包括 SUBLOCADE（丁丙諾啡緩釋）月度注射劑；SUBOXONE 薄膜（丁丙諾啡和納洛酮舌下薄膜）；SUBOXONE 片劑（丁丙諾啡和納洛酮舌下片）和 SUBUTEX 片劑（丁丙諾啡舌下片）。該公司用於治療阿片類藥物障礙 (OUD) 的產品包括用於逆轉阿片類藥物過量用藥的 OPVEE（納美芬）鼻噴霧劑和用於治療美國成人精神分裂症的 PERSERIS（利培酮）緩釋注射混懸液。該公司的產品組合銷往 37 個國家。
公司簡介
公司代碼INDV
公司名稱Indivior PLC
上市日期Dec 24, 2014
CEOMr. Joseph J. (Joe) Ciaffoni
員工數量1030
證券類型Ordinary Share
年結日Dec 24
公司地址234 Bath Road
城市SLOUGH
上市交易所NASDAQ Global Select Consolidated
國家United Kingdom
郵編SL1 4EE
電話448043791090
網址https://www.indivior.com/en
公司代碼INDV
上市日期Dec 24, 2014
CEOMr. Joseph J. (Joe) Ciaffoni
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.25%
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
132.64K
+42.74%
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
121.74K
--
Mr. Hillel West
Mr. Hillel West
Chief Manufacturing and Supply Officer
Chief Manufacturing and Supply Officer
121.72K
+338.91%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
56.00K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
15.00K
--
Ms. Juliet Thompson
Ms. Juliet Thompson
Senior Non-Executive Independent Director
Senior Non-Executive Independent Director
9.63K
+150.00%
Dr. Keith Humphreys
Dr. Keith Humphreys
Non-Executive Independent Director
Non-Executive Independent Director
3.88K
+63.05%
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
760.00
--
Mr. Stuart (Tony) Kingsley
Mr. Stuart (Tony) Kingsley
Independent Non-Executive Director
Independent Non-Executive Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.25%
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
132.64K
+42.74%
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
121.74K
--
Mr. Hillel West
Mr. Hillel West
Chief Manufacturing and Supply Officer
Chief Manufacturing and Supply Officer
121.72K
+338.91%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
56.00K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
15.00K
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
United States
222.00M
83.46%
Rest of World
44.00M
16.54%
業務
地區
暫無數據
股東統計
更新時間: 7月2日 週三
更新時間: 7月2日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Two Seas Capital LP
9.35%
Oaktree Capital Management, L.P.
8.82%
Deerfield Management Company, L.P.
8.47%
BlackRock Investment Management (UK) Ltd.
6.63%
Goldman Sachs International
6.58%
Other
60.15%
持股股東
持股股東
佔比
Two Seas Capital LP
9.35%
Oaktree Capital Management, L.P.
8.82%
Deerfield Management Company, L.P.
8.47%
BlackRock Investment Management (UK) Ltd.
6.63%
Goldman Sachs International
6.58%
Other
60.15%
股東類型
持股股東
佔比
Hedge Fund
39.97%
Investment Advisor/Hedge Fund
20.90%
Investment Advisor
14.44%
Research Firm
10.94%
Individual Investor
3.88%
Pension Fund
0.36%
Family Office
0.21%
Bank and Trust
0.20%
Venture Capital
0.04%
Other
9.06%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
349
120.01M
95.70%
+8.27M
2025Q1
380
119.99M
96.15%
-1.70M
2024Q4
382
116.83M
93.64%
-10.43M
2024Q3
369
117.73M
91.72%
-15.91M
2024Q2
352
119.29M
90.10%
-8.99M
2024Q1
341
129.79M
96.57%
+3.79M
2023Q4
322
124.43M
92.28%
+2.93M
2023Q3
321
114.40M
84.40%
+17.06M
2023Q2
296
115.50M
83.90%
+12.51M
2023Q1
259
96.50M
70.33%
+1.18M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Two Seas Capital LP
12.07M
9.68%
+191.47K
+1.61%
Jun 17, 2025
Oaktree Capital Management, L.P.
11.01M
8.82%
+293.23K
+2.74%
Mar 31, 2025
Deerfield Management Company, L.P.
10.57M
8.47%
+4.00M
+60.90%
Mar 31, 2025
BlackRock Investment Management (UK) Ltd.
8.27M
6.63%
+8.27M
--
Jun 27, 2025
Goldman Sachs International
8.21M
6.58%
+1.28M
+18.51%
Mar 31, 2025
Madison Avenue Partners LP
7.79M
6.25%
+2.76M
+54.85%
Mar 31, 2025
Rubric Capital Management LP
4.70M
3.77%
+1.17M
+33.20%
Apr 21, 2025
The Vanguard Group, Inc.
4.61M
3.69%
+71.54K
+1.58%
Mar 31, 2025
UBS Financial Services, Inc.
3.53M
2.83%
+2.69M
+323.54%
Mar 31, 2025
Sirovich (Matthew I.)
3.42M
2.74%
+249.62K
+7.87%
Sep 30, 2024
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares MSCI United Kingdom Small-Cap ETF
0.34%
ProShares Ultra Nasdaq Biotechnology
0.21%
Invesco Nasdaq Biotechnology ETF
0.21%
Franklin US Small Cap Multifactor Index ETF
0.17%
Vanguard US Multifactor ETF
0.16%
Invesco International BuyBack Achievers ETF
0.13%
iShares Intl Small Cap Equity Factor ETF
0.11%
SPDR S&P International Small Cap ETF
0.11%
iShares MSCI Europe Small-Cap ETF
0.1%
iShares Russell 2000 Growth ETF
0.09%
查看更多
iShares MSCI United Kingdom Small-Cap ETF
佔比0.34%
ProShares Ultra Nasdaq Biotechnology
佔比0.21%
Invesco Nasdaq Biotechnology ETF
佔比0.21%
Franklin US Small Cap Multifactor Index ETF
佔比0.17%
Vanguard US Multifactor ETF
佔比0.16%
Invesco International BuyBack Achievers ETF
佔比0.13%
iShares Intl Small Cap Equity Factor ETF
佔比0.11%
SPDR S&P International Small Cap ETF
佔比0.11%
iShares MSCI Europe Small-Cap ETF
佔比0.1%
iShares Russell 2000 Growth ETF
佔比0.09%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
